ISCHEMIA Trial and the Significance of MI
During the past decade, the treatment of choice for chronic coronary syndromes (CCS) has been a contentious issue. Whether revascularisation, either percutaneous or surgical, or optimal medical therapy, offers better prognosis in terms of mortality, MI, and symptom relief, has yet to be confirmed. T...
Main Authors: | Eduardo A Arias, Félix Damas-de los Santos, Heriberto Ontiveros-Mercado |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-10-01
|
Series: | Interventional Cardiology: Reviews, Research, Resources |
Online Access: | https://www.icrjournal.com/articles/ischemia-trial-and-the-significance-of-mi |
Similar Items
-
miRNA Involvement in Cerebral Ischemia-Reperfusion Injury
by: Maria-Adriana Neag, et al.
Published: (2022-06-01) -
The ISCHEMIA Trial: And the Winner Is… the Patient
by: Pablo Avanzas, et al.
Published: (2021-03-01) -
Laparoscopic radical prostatectomy does not cause significant tissue ischemia
by: Nado Vodopija, et al.
Published: (2006-12-01) -
After ischemia trial, what is the role of ischemia detection on noninvasive testing?
by: Abdul Rahman Arabi, et al.
Published: (2020-01-01) -
ISCHEMIA Trial: Key Questions and Answers
by: Jose Lopez-Sendon, et al.
Published: (2021-09-01)